Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Baxter International Inc (NYSE:BAX)

63.59
Delayed Data
As of Oct 20
 +0.12 / +0.19%
Today’s Change
43.13
Today|||52-Week Range
64.75
+43.41%
Year-to-Date
Dan Loeb Buys Activist Stake in Dover Corp in 3rd Quarter
Oct 20 / GuruFocus News - Paid Partner Content
Baxter International (BAX) Q3 Earnings: What's in Store?
Oct 20 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close63.47
Today’s open63.71
Day’s range63.40 - 63.91
Volume2,738,550
Average volume (3 months)2,371,605
Market cap$34.6B
Dividend yield1.01%
Data as of 10/20/2017

Growth & Valuation

Earnings growth (last year)+410.02%
Earnings growth (this year)+21.82%
Earnings growth (next 5 years)+14.00%
Revenue growth (last year)+1.96%
P/E ratio38.5
Price/Sales2.40
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
ALXNAlexion Pharmaceutic...-1.44-1.03%
ZTSZoetis Inc+0.36+0.55%
VRTXVertex Pharmaceutica...+0.03+0.02%
INCYIncyte Corp-0.08-0.07%
Data as of 10/20/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.59
Annual revenue (last year)$10.2B
Annual profit (last year)$4.9B
Net profit margin48.86%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Joe Almeida
Vice President-
Operations
Scott Pleau
Corporate headquarters
Deerfield, Illinois

Forecasts